Lantern Pharma Inc. Stock Analysis & AI Score
Lantern Pharma Inc. (LTRN) has an ST Score of 18.4 (D), driven by its Valuation (B) and held back by its Growth (F). Analysts rate it Buy.
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Lantern Pharma Inc. (LTRN) has an ST Score of 18.4 (D), driven by its Valuation (B) and held back by its Growth (F). Analysts rate it Buy.
- Strongest
- ValuationB
- Weakest
- GrowthF
All factor grades
- ValuationB
- Financial StrengthC
- ProfitabilityF
- MomentumF
- GrowthF
- Piotroski1/9
Contact
LTRN stock: frequently asked questions
What is LTRN's ST Score?
Lantern Pharma Inc. (LTRN) has an ST Score of 18.4 (D), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is LTRN a buy, hold, or sell?
Analysts rate LTRN a Buy. Our ST Score grades it D (18.4/100). The ST Score is a data-driven signal, not a recommendation.
What are LTRN's factor grades?
Valuation B, Profitability F, Financial Strength C, Momentum F, Growth F.
What is LTRN's valuation grade?
Lantern Pharma Inc. (LTRN) earns a valuation grade of B, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is LTRN's growth grade?
Lantern Pharma Inc. (LTRN) earns a growth grade of F, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is LTRN's profitability grade?
Lantern Pharma Inc. (LTRN) earns a profitability grade of F, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is LTRN's financial strength grade?
Lantern Pharma Inc. (LTRN) earns a financial strength grade of C, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is LTRN's Piotroski score?
Lantern Pharma Inc. (LTRN) has a Piotroski F-Score of 1 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.